|
1.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2.
|
Gill S, Loprinzi CL, Sargent DJ, Thomé SD,
Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE,
Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP and
Goldberg RM: Pooled analysis of fluorouracil-based adjuvant therapy
for stage II and III colon cancer: who benefits and by how much? J
Clin Oncol. 22:1797–1806. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
André T, Quinaux E, Louvet C, Colin P,
Gamelin E, Bouche O, Achille E, Piedbois P, Tubiana-Mathieu N,
Boutan-Laroze A, Flesch M, Lledo G, Raoul Y, Debrix I, Buyse M and
de Gramont A: Phase III study comparing a semimonthly with a
monthly regimen of fluorouracil and leucovorin as adjuvant
treatment for stage II and III colon cancer patients: final results
of GERCOR C96.1. J Clin Oncol. 25:3732–3738. 2007.PubMed/NCBI
|
|
4.
|
Mamounas E, Wieand S, Wolmark N, Wolmark
N, Bear HD, Atkins JN, Song K, Jones J and Rockette H: Comparative
efficacy of adjuvant chemotherapy in patients with Dukes’ B versus
Dukes’ C colon cancer: results from four National Surgical Adjuvant
Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and
C-04). J Clin Oncol. 17:1349–1355. 1999.
|
|
5.
|
Le Voyer TE, Sigurdson ER, Hanlon AL,
Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ and Haller DG: Colon
cancer survival is associated with increasing number of lymph nodes
analyzed: a secondary survey of intergroup trial INT-0089. J Clin
Oncol. 21:2912–2919. 2003.PubMed/NCBI
|
|
6.
|
Agre P, King LS, Yasui M, Guggino WB,
Ottersen OP, Fujiyoshi Y, Engel A and Nielsen S: Aquaporin water
channels - from atomic structure to clinical medicine. J Physiol.
542:3–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Verkman AS and Mitra AK: Structure and
function of aquaporin water channels. Am J Physiol Renal Physiol.
278:F13–F28. 2000.PubMed/NCBI
|
|
8.
|
Mobasheri A and Marples D: Expression of
the AQP-1 water channel in normal human tissues: a semiquantitative
study using tissue microarray technology. Am J Physiol Cell
Physiol. 286:C529–C537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bondy C, Chin E, Smith BL, Preston GM and
Agre P: Developmental gene expression and tissue distribution of
the CHIP28 water-channel protein. Proc Natl Acad Sci USA.
90:4500–4504. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Moon C, Soria JC, Jang SJ, Lee J, Obaidul
Hoque M, Sibony M, Trink B, Chang YS, Sidransky D and Mao L:
Involvement of aquaporins in colorectal carcinogenesis. Oncogene.
22:6699–6703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Yang JH, Shi YF, Chen XD and Qi WJ: The
influence of aquaporin-1 and microvessel density on ovarian
carcinogenesis and ascites formation. Int J Gynecol Cancer.
16:400–405. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Yiang J: Aquaporin-1 activity of plasma
membrane affects HT20 colon cancer cell migration. IUBMB Life.
61:1001–1009. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Hu J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. FASEB J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Otterbach F, Callies R, Adamzik M, Kimmig
R, Siffert W, Schmid KW and Bankfalvi A: Aquaporin (AQP1)
expression is a novel characteristic feature of a particularly
aggresive subgroup of basal-like breast carcinomas. Breast Cancer
Res Treat. 120:67–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Huang Y, Murakami T, Sano F, Kondo K,
Nakaigawa N, Kishida T, Kubota Y, Nagashima Y and Yao M: Expression
of aquaporin 1 in primary renal tumors: a prognostic indicator for
clear-cell renal cell carcinoma. Eur Urol. 56:690–698. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Machida Y, Ueda Y, Shimasaki M, Sato K,
Sagawa M, Katsuda S and Sakuma T: Relationship of aquaporin 1, 3,
and 5 expression in lung cancer cells to cellular differentiation,
invasive growth, and metastasis potential. Hum Pathol. 42:669–678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bin K and Shi-Peng Z: Acetazolamide
inhibits aquaporin-1 expression and colon cancer xenograft tumor
growth. Hepatogastroenterology. 58:110–111. 2011.PubMed/NCBI
|
